The Beauty Health Company (NASDAQ:SKIN) Stock Has Consensus Price Target of $16.67

Shares of The Beauty Health Company (NASDAQ:SKIN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $16.67.

Several analysts recently issued reports on SKIN shares. Raymond James Financial set a $14.00 price target on Beauty Health in a report on Monday, November 9th. Canaccord Genuity Group set a $11.00 target price on Beauty Health and gave the stock a “hold” rating in a research report on Thursday, October 22nd. Citigroup reiterated a “hold” rating on shares of Beauty Health in a research note on Thursday, October 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, October 21st. Finally, TD Cowen reissued a “hold” rating and issued a $14.00 price target (up from $0.90) on shares of Beauty Health in a research note on Monday, November 9th.

View Our Latest Stock Report on Beauty Health

Beauty Health Trading Down 3.1%

NASDAQ:SKIN opened at $11.77 on Friday. The company has a market cap of $76.98 million, a PE ratio of -4.30 and a beta of 1.05. The business’s 50 day moving average is $12.46 and its two-hundred day moving average is $15.60. The company has a quick ratio of 2.22, a current ratio of 2.89 and a debt-to-equity ratio of 4.36. Beauty Health has a 52 week low of $9.68 and a 52 week high of $33.00.

Beauty Health (NASDAQ:SKIN – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($1.33) by $1.19. Beauty Health had a negative net margin of 6.34% and a negative return on equity of 32.16%. The firm had revenue of $69.17 million during the quarter, compared to the consensus estimate of $67.97 million. On average, analysts predict that Beauty Health will post -2.56 EPS for the current year.

Institutional Trading of Beauty Health

A hedge fund recently raised its position in Beauty Health stock. Renaissance Technologies LLC boosted its position in shares of The Beauty Health Company (NASDAQ:SKIN – Free Report) by 29.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 283,791 shares of the company’s stock after buying an additional 64,900 shares during the quarter. Renaissance Technologies LLC owned 0.22% of Beauty Health worth $253,000 at the end of the most recent quarter. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Company Profile

(Get Free Report)

The Beauty Health Company develops and sells products and services for the beauty and skincare market. Its best-known brand, Hydrafacial, offers a facial treatment that uses specialized equipment and serums to cleanse, exfoliate and hydrate the skin. The company supplies Hydrafacial devices and related consumable products to professional providers, including spas, dermatology practices and other skincare businesses. It also offers skincare products associated with its treatments. Based in Long Beach, California, BeautyHealth serves customers through professional and consumer channels in markets around the world.

See Also

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.